Informações:
Falhas:
ID
23410
Descrição
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00366301
Link
https://clinicaltrials.gov/show/NCT00366301
Palavras-chave
Versões (1)
- 03/07/2017 03/07/2017 -
Transferido a
3 de julho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes NCT00366301
Eligibility Type 2 Diabetes NCT00366301
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT00366301
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
men and women aged 18 to 79
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | oral medication | Metformin
Item
type 2 diabetes, treated only by diet or oral drugs other than metformin
boolean
C0011860 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0175795 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0012159 (UMLS CUI [2])
C0175795 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
Glycosylated hemoglobin A
Item
hba1c greater than or equal to 7% and less than or equal to 10%
boolean
C0019018 (UMLS CUI [1])
C-reactive protein measurement
Item
c-reactive protein greater than or equal to 2 mg/l
boolean
C0201657 (UMLS CUI [1])
Metformin | Insulin
Item
baseline use of metformin or insulin
boolean
C0025598 (UMLS CUI [1])
C0021641 (UMLS CUI [2])
C0021641 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent | Ketoacidosis | Anti-GAD antibody positive
Item
type 1 diabetes, history of ketoacidosis or positive anti-gad antibody
boolean
C0011854 (UMLS CUI [1])
C0220982 (UMLS CUI [2])
C1167896 (UMLS CUI [3])
C0220982 (UMLS CUI [2])
C1167896 (UMLS CUI [3])
Congestive heart failure Requirement Pharmacotherapy
Item
history of congestive heart failure requiring drug therapy
boolean
C0018802 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,3])
Liver diseases
Item
active liver disease
boolean
C0023895 (UMLS CUI [1])
Renal Insufficiency
Item
kidney impairment
boolean
C1565489 (UMLS CUI [1])
Statins | Fibric Acids | Angiotensin Receptor Antagonists | Anti-Inflammatory Agents, Non-Steroidal | Adrenal Cortex Hormones | Statins Dose Changed | Fibric Acids Dose Changed | Angiotensin Receptor Antagonists Dose Changed | Non-Steroidal Anti-Inflammatory Agents Dose Changed | Adrenal Cortex Hormones Dose Changed
Item
recent initiation or change in dose of statins, fibric acid derivatives, angiotensin receptor blockers, nonsteroidal anti-inflammatory agents, or corticosteroids
boolean
C0360714 (UMLS CUI [1])
C2936462 (UMLS CUI [2])
C0815017 (UMLS CUI [3])
C0003211 (UMLS CUI [4])
C0001617 (UMLS CUI [5])
C0360714 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0392747 (UMLS CUI [6,3])
C2936462 (UMLS CUI [7,1])
C0178602 (UMLS CUI [7,2])
C0392747 (UMLS CUI [7,3])
C0815017 (UMLS CUI [8,1])
C0178602 (UMLS CUI [8,2])
C0392747 (UMLS CUI [8,3])
C0003211 (UMLS CUI [9,1])
C0178602 (UMLS CUI [9,2])
C0392747 (UMLS CUI [9,3])
C0001617 (UMLS CUI [10,1])
C0178602 (UMLS CUI [10,2])
C0392747 (UMLS CUI [10,3])
C2936462 (UMLS CUI [2])
C0815017 (UMLS CUI [3])
C0003211 (UMLS CUI [4])
C0001617 (UMLS CUI [5])
C0360714 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0392747 (UMLS CUI [6,3])
C2936462 (UMLS CUI [7,1])
C0178602 (UMLS CUI [7,2])
C0392747 (UMLS CUI [7,3])
C0815017 (UMLS CUI [8,1])
C0178602 (UMLS CUI [8,2])
C0392747 (UMLS CUI [8,3])
C0003211 (UMLS CUI [9,1])
C0178602 (UMLS CUI [9,2])
C0392747 (UMLS CUI [9,3])
C0001617 (UMLS CUI [10,1])
C0178602 (UMLS CUI [10,2])
C0392747 (UMLS CUI [10,3])